Elvina Almuradova, Oncology Unit Lead at Can Hospitals Turkey, shared a post on LinkedIn about a paper she co-authored with colleagues published in Expert Review of Pharmacoeconomics and Outcomes Research:
“New Research Alert!
Our latest study explores how Turkish medical oncologists navigate the balance between international treatment guidelines and national reimbursement policies in daily practice.
Key Findings:
- 94% find international guidelines essential, but 62% struggle with real-world applicability.
- 57% prefer national guidelines due to better alignment with local policies.
What do you think? Should treatment guidelines be more adaptable to local healthcare systems?”
Authors: Ozgur Tanriverdi et al.
More posts featuring Elvina Almuradova.